Table 4.

Frequency of lymphoma and mean survival time (in brackets) of ICAM-1–deficient mice injected intravenously with 164T2 and 164T2S11 lymphoma cells

Lymphoma Cell Line Male Female
164T2  0/15  0/4 
164T2S11  9/9 (16.8 days)  7/8 (19 days) 
Lymphoma Cell Line Male Female
164T2  0/15  0/4 
164T2S11  9/9 (16.8 days)  7/8 (19 days) 

The experiment was terminated at day 90. The data are representative of at least 4 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal